Skip to main content

Dobutamine Injection

Last Updated: January 19, 2023
Status: Current

Products Affected - Description
    • Dobutamine injection, Baxter, 1 mg/mL, 250 mL premixed bag, 12 count, NDC 00338-1073-02
    • Dobutamine injection, Baxter, 2 mg/mL, 250 mL premixed bag, 12 count, NDC 00338-1075-02
    • Dobutamine injection, Baxter, 4 mg/mL, 250 mL premixed bag, 12 count, NDC 00338-1077-02
    • Dobutamine injection, Pfizer, 1 mg/mL, 250 mL premixed bag, 12 count, NDC 00409-2346-32
    • Dobutamine injection, Pfizer, 12.5 mg/mL, 20 mL vial, 1 count, NDC 00409-2344-01
    • Dobutamine injection, Pfizer, 12.5 mg/mL, 20 mL vial, 10 count, NDC 00409-2344-02
    • Dobutamine injection, Pfizer, 2 mg/mL, 250 mL premixed bag, 12 count, NDC 00409-2347-32
    • Dobutamine injection, Pfizer, 4 mg/mL, 250 mL premixed bag, 12 count, NDC 00409-3724-32
Reason for the Shortage
    • Baxter has dobutamine on shortage due to manufacturing delays of a third-party supplier.
    • Pfizer has dobutamine on shortage due to manufacturing delays. FDA has approved extended expiry for several dobutamine presentations. These will be available at https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-drug-shortages.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Baxter has dobutamine 1 mg/mL 250 mL premixed bags, 2 mg/mL 250 mL premixed bags, and 4 mg/mL 250 mL premixed bags on allocation.
    • Pfizer has dobutamine 1 mg/mL 250 mL premixed bags available in limited supply. The 2 mg/mL 250 mL premixed bags are available in limited supply. The 4 mg/mL 250 mL premixed bags are available in limited supply. The 12.5 mg/mL 20 mL vials in 1 count are on back order and the company estimates a release date of February 2023. The 12.5 mg/mL 20 mL vials in 10 count are available in limited supply.

Alternative Agents & Management

    • Additional information can be found in a guidance document at: https://www.acc.org/Latest-in-Cardiology/Articles/2022/08/02/12/42/What-You-Need-to-Know-Guidance-For-Clinicians-on-Dobutamine-Shortage

Updated

Updated January 19, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 1, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.